Skip to main content
. 2021 Jan 7;13(1):72. doi: 10.3390/pharmaceutics13010072

Figure 5.

Figure 5

Mean time between fluocinolone acetonide implant and initiation of additional intravitreal DME treatments according to chronicity of diabetic macular edema at the time of injection, in real-world studies evaluating the efficacy of the implant for diabetic macular edema (n = 6 studies).